| Financial Year |
March 31 2022 |
| Monetary Funds |
633,244,971.11 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
43,411,358.86 |
| Accounts Receivable |
107,162,531.83 |
| Advances to Suppliers |
5,839,639.79 |
| Other Receivables |
1,774,101.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
94,583,032.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
36,023,404.15 |
| Total Current Assets |
934,514,730.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
313,050,074.53 |
| Under-construction Projects |
51,557,359.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
81,240,323.62 |
| R&D expenses |
-- |
| Goodwill |
124,972.13 |
| Long-Term Deferred and Prepaid Expenses |
833,109.92 |
| Deferred Income Tax Assets |
5,549,707.82 |
| Other Non-Current Assets |
22,814,708.87 |
| Sub-Total of Non-Current Assets |
497,706,328.02 |
| Total Assets |
1,432,221,058.36 |
| Short-Term Loans |
112,741,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
36,241,532.68 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,395,507.77 |
| Taxes Payable |
5,667,845.31 |
| Interest Payable |
-- |
| Dividend Payable |
119,013.20 |
| Other payables |
9,424,896.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,002,066.06 |
| Other Current Liabilities |
34,587,132.99 |
| Sub-Total of Current Liabilities |
208,447,746.59 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,841,897.98 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
28,520,423.19 |
| Total Liabilities |
236,968,169.78 |
| Paid-In Capital(Or Share Stock) |
100,000,000.00 |
| Capital Surplus |
673,172,341.56 |
| Surplus Reserve |
38,786,763.39 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
387,142,625.47 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,195,252,888.58 |
| Owner's Equity（Stockholder's Equity） |
1,195,252,888.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,432,221,058.36 |
